Qi Qi's research while affiliated with University of Connecticut and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (2)
Background:
The ultimate validation of a clinical marker for Alzheimer's disease (AD) is its association with AD neuropathology.
Objective:
To examine how well the Stages of Objective Memory Impairment (SOMI) system predicts intermediate/high AD neuropathologic change and extent of neurofibrillary tangle (NFT) pathology defined by Braak stage, i...
Background:
The ultimate validation of a clinical marker for Alzheimer's disease (AD) is its association with AD neuropathology.
Objective:
To identify clinical measures that predict pathology, we evaluated the relationships of the picture version of the Free and Cued Selective Reminding Test (pFCSRT + IR), the Mini-Mental State Exam (MMSE), and...
Citations
... The VSTMBT Parra, Abrahams, Logie, Méndez, et al., 2010) and the FCSRT (Grober et al., 1988) have proved effective to identify at risk individuals throughout the AD continuum with high sensitivity and specificity, particularly in the early stages of the disease (Cecchini et al., 2021;Grober et al., 2021;Rentz et al., 2010). Although, these tests tap into memory binding abilities, they inform about different binding functions (Parra, 2022;Parra, Calia, et al., 2022). ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/273643586453512-1442253123886_Q64/Ellen-Grober.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/278593377718279-1443433245421_Q64/Jason-Hassenstab-2.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/914371395985409-1595014537435_Q64/Richard-Lipton.jpg)
... In typical AD, reported subjective memory complaints (SMC) tend to be the earliest signs of EM deficits (±4-8 years prior to other executive failures), which are AD's most prominent cognitive dysfunction, and highly predictive of incident dementia [2,5,[7][8][9][10][11]. AD assessments largely result from SMC, often self-reported when the patient is already on the path to clinical symptomatology [2,5,[7][8][9]11]. ...
